Abstract
OBJECTIVE:
To identify factors associated with continuous positive airway pressure (CPAP) and/or intubation for children with bronchiolitis.
METHODS:
We performed a 16-center, prospective cohort study of hospitalized children aged <2 years with bronchiolitis. For 3 consecutive years from November 1 until March 31, beginning in 2007, researchers collected clinical data and a nasopharyngeal aspirate from study participants. We oversampled children from the ICU. Samples of nasopharyngeal aspirate were tested by polymerase chain reaction for 18 pathogens.
RESULTS:
There were 161 children who required CPAP and/or intubation. The median age of the overall cohort was 4 months; 59% were male; 61% white, 24% black, and 36% Hispanic. In the multivariable model predicting CPAP/intubation, the significant factors were: age <2 months (odds ratio [OR] 4.3; 95% confidence interval [CI] 1.7–11.5), maternal smoking during pregnancy (OR 1.4; 95% CI 1.1–1.9), birth weight <5 pounds (OR 1.7; 95% CI 1.0–2.6), breathing difficulty began <1 day before admission (OR 1.6; 95% CI 1.2–2.1), presence of apnea (OR 4.8; 95% CI 2.5–8.5), inadequate oral intake (OR 2.5; 95% CI 1.3–4.3), severe retractions (OR 11.1; 95% CI 2.4–33.0), and room air oxygen saturation <85% (OR 3.3; 95% CI 2.0–4.8). The optimism-corrected c-statistic for the final model was 0.80.
CONCLUSIONS:
In this multicenter study of children hospitalized with bronchiolitis, we identified several demographic, historical, and clinical factors that predicted the use of CPAP and/or intubation, including children born to mothers who smoked during pregnancy. We also identified a novel subgroup of children who required mechanical respiratory support <1 day after respiratory symptoms began.
KEY WORDS: bronchiolitis, continuous positive airway pressure, intubation, ICU, respiratory syncytial virus, human rhinovirus
What’s Known on This Subject:
Bronchiolitis is one of the most common infectious respiratory conditions of early childhood, and most children have a mild clinical course. Unfortunately, the small subgroup of children requiring continuous positive airway pressure and/or intubation remains ill-defined.
What This Study Adds:
In children with bronchiolitis, we found several demographic, historical, and clinical factors that predicted the need for mechanical respiratory support including in utero smoke exposure. We also found a novel subgroup of children with bronchiolitis who have a rapid respiratory decline.
Bronchiolitis is one of the most common infectious respiratory conditions of early childhood1,2 and is associated with multiple different viruses.3 Most children who develop bronchiolitis have a mild course, but 2% to 3% of children with bronchiolitis are hospitalized4,5 and <1% are admitted to an ICU, are intubated, or die.6–9 Despite objective physical examination findings for respiratory distress (eg, respiratory rate and degree of retractions), the difficulty and uncertainty of determining the appropriate level of supportive care for children with bronchiolitis is well documented by marked variability in acute care and disposition.7,10–12 One reason for this variability may be that the clinical course for children with bronchiolitis tends to be variable and dynamic.13
Indeed, the subgroup of children with severe bronchiolitis requiring continuous positive airway pressure (CPAP) and/or intubation remains ill defined. This lack of understanding may hinder treatment advances, as well as mechanistic research, because this group of children may respond differently to medications and/or have different long-term clinical outcomes.14,15 Researchers have identified demographic, environmental, medical history, and laboratory risk factors for severe bronchiolitis1,5,8,16–24 in single-center studies,25–28 retrospectively,28,29 in children with respiratory syncytial virus (RSV) only,6 and in children with RSV before the use of palivizumab.6,25 In contrast, we performed a prospective, multicenter, multiyear study of >2000 children hospitalized with bronchiolitis to investigate the historical, environmental, clinical, and pathogenic factors associated with CPAP and/or intubation. We hypothesized that children aged <2 months, with low birth weight, and with preadmission room air oxygen saturation <90% would predict the need for CPAP and/or intubation.
Methods
Study Design
We conducted a prospective, multicenter cohort study for 3 consecutive years during the 2007 to 2010 winter seasons as part of the Multicenter Airway Research Collaboration (MARC), a program of the Emergency Medicine Network (www.emnet-usa.org). The number of participating sites varied over the 3 years: 13 sites in year 1; 16 sites in year 2; and 14 sites in year 3. Each month from November 1 until March 31, site investigators across 12 US states used a standardized protocol to enroll a target number of consecutive patients from the inpatient wards and the ICU. We aimed to enroll 20% of our total sample from the ICU. To oversample children in the ICU, the ward and ICU enrollments were separate. Once the site reached its target enrollment for that month, the investigators would stop enrollment until the beginning of the following month.
All patients were treated at the discretion of the treating physician. Inclusion criteria were an attending physician’s diagnosis of bronchiolitis, age <2 years, and the ability of the parent/guardian to give informed consent. The exclusion criteria were previous enrollment and transfer to a participating hospital >48 hours after the original admission time. All consent and data forms were translated into Spanish. The institutional review board at each of the 16 participating hospitals approved the study.
Data Collection
Investigators conducted a structured interview that assessed patients’ demographic characteristics, medical and environmental history, duration of symptoms, and details of the acute illness. The interview included the question, “Did the mother of [child] smoke cigarettes during the pregnancy?” Relevant comorbid medical disorders included review of respiratory, cardiac, neurologic, gastrointestinal, and immunologic diseases. Emergency department (ED) and daily hospital clinical data, including respiratory rates, daily respiratory rate trends, clinical assessment of degree of retractions (collapsed for analysis into none, mild, and moderate/severe), oxygen saturation, daily oxygen saturation trends, medical management, and disposition were obtained by chart review. These data were manually reviewed at the Emergency Medicine Network Coordinating Center, and site investigators were queried about missing data and discrepancies identified by these manual data checks.
Nasopharyngeal Aspirate Collection and Virology Testing
Nasopharyngeal aspirates (NPAs) were performed by using a standardized protocol. Designated site personnel were trained by use of a lecture, written instructions, and video. All of the sites used the same collection equipment (Medline Industries, Mundelein, IL) and collected 98% of the samples within 24 hours of a child’s arrival on the medical ward or ICU. Once collected, the NPA sample was added to transport medium. After collection, the NPA samples were immediately placed on ice and then stored at −80°C. Frozen samples were batch shipped on dry ice overnight to the central laboratory at Baylor College of Medicine, where they were stored at −80°C.
Polymerase Chain Reaction Assay
All polymerase chain reaction (PCR) assays were conducted as singleplex or duplex 2-step real-time PCR. Real-time reverse transcriptase PCR was used for the detection of RSV types A and B, human rhinovirus (HRV), parainfluenza virus types 1, 2, and 3, influenza virus types A and B, 2009 novel H1N1, human metapneumovirus, coronaviruses NL-63, HKU1, OC43, and 229E, enterovirus, adenovirus, Mycoplasma pneumoniae, and Bordetella pertussis. These tests are routinely conducted in the central laboratory of one of the investigators (P.A.P.) and details of the primers and probes have been described.30–32 All real-time reverse transcriptase-PCR assays were tested in duplicate, and samples with incongruent values were retested.
Statistical Analyses
All analyses were performed by using Stata 11.2 (Stata Corp, College Station, TX). Data are presented as proportions with 95% confidence intervals (95% CIs) and medians with interquartile ranges (IQR).
We performed univariate analyses by using χ2, Fisher exact test, and Kruskal-Wallis test, as appropriate. All P values were 2-tailed, with P < .05 considered statistically significant. Multivariable logistic regression was conducted to evaluate independent predictors of CPAP/ intubation, defined as any instance of patient requiring CPAP and/or intubation during the admission. We used CPAP/intubation as the outcome of interest because this outcome has less variability than admission to the ICU.33–36 Factors were tested for inclusion in the model if they were found to be associated with the outcome in unadjusted analyses (P < .20) or were considered potentially clinically significant. An optimism-corrected c-statistic was used to determine model discrimination,37 and the Hosmer-Lemeshow test was used to determine model calibration.38 The final regression model accounts for potential clustering by site and was validated by using bootstrapping.37 The full model was bootstrapped 1000 times and bias-corrected and accelerated 95% CIs were obtained. Results are reported as odds ratios (ORs) with bias-corrected and accelerated 95% CI.
In addition, we used descriptive statistics to better characterize the group of children whose condition declined rapidly. These children began experiencing difficulty breathing <1 day before the ED visit (as reported by parents/caregiver) and required CPAP/intubation on the first day of their inpatient stay.
Results
Of the 2207 enrolled children, 379 (17%) were enrolled in the ICU. Of these 379 children, 161 (42%) required CPAP and/or intubation. Of these 161 children, 59 (37%) required CPAP, 64 (40%) were intubated, and 38 (23%) had both CPAP and intubation. Overall, the median age of the 2207 enrolled children was 4 months (IQR, 2–9 months); 61% were born in fall or winter months (October to March); 59% were male; and 61% were white (Table 1). Most children had nonprivate health insurance, were born term, had a birth weight of ≥7 pounds, were breastfed, and had no parental history of asthma. The most frequently detected pathogens among enrolled children were RSV-A (43%), RSV-B (30%), and HRV (26%). The median overall hospital length of stay was 2 days (IQR, 1–4 days).
TABLE 1.
Characteristics | n | % |
---|---|---|
Age in months | ||
<2 | 628 | 28 |
2–5.9 | 777 | 35 |
6–11.9 | 491 | 22 |
≥12 | 311 | 14 |
Month of birth | ||
October–March | 1345 | 61 |
April–September | 862 | 39 |
Gender | ||
Male | 1311 | 59 |
Female | 896 | 41 |
Race | ||
White | 1357 | 61 |
Black | 539 | 24 |
Other or missing | 311 | 14 |
Hispanic | 802 | 36 |
Insurance | ||
Nonprivate | 1494 | 69 |
Private | 684 | 31 |
Gestational age, wk | ||
<32 | 142 | 6 |
32–36 | 391 | 18 |
≥37 or term | 1660 | 76 |
Birth weight, lbs | ||
<5 | 281 | 13 |
≥5 | 768 | 35 |
≥7 | 1132 | 52 |
Mother’s age, median (IQR) | 2198 | 27 (23–33) |
Is or was breastfed | 1334 | 61 |
Smoked during pregnancy | 334 | 15 |
Exposure to smoke | 284 | 13 |
Family history of asthma | ||
Neither parent | 1486 | 67 |
Either mother or father | 594 | 27 |
Both parents | 87 | 4 |
Don't know/missing | 40 | 2 |
History of infant wheezing | 498 | 23 |
History of infant eczema | 334 | 15 |
History of infant intubation | 225 | 10 |
Major, relevant, comorbid medical disorder | 460 | 21 |
When difficulty breathing began (preadmission) | ||
≥1 d | 1539 | 71 |
<1 d | 590 | 27 |
No difficulty preadmission | 47 | 2 |
Presence of apnea (chart) | 153 | 7 |
Weight (lbs), median (IQR) | 2152 | 13 (9–18) |
Temperature (F), median (IQR) | 2170 | 99.5 (98.6–100.6) |
Pulse (beats per min), median (IQR) | 2177 | 161 (148–176) |
Respiratory rate (breaths per min), median (IQR) | 2185 | 48 (40–60) |
Retractions | ||
None | 483 | 22 |
Mild | 925 | 42 |
Moderate | 554 | 25 |
Severe | 87 | 4 |
Missing | 158 | 7 |
Oxygen saturation by pulse oximeter or ABG | ||
<85 | 89 | 4 |
85–87.9 | 66 | 3 |
88–89.9 | 96 | 4 |
90–93.9 | 362 | 17 |
≥94 | 1546 | 72 |
Oral intake | ||
Adequate | 955 | 43 |
Inadequate | 938 | 43 |
Missing | 314 | 14 |
WBC, median (IQR) | 856 | 11 (9–15) |
Platelets, median (IQR) | 842 | 396 (314–490) |
Sodium, median (IQR) | 631 | 138 (136–139) |
Adenovirus | 173 | 8 |
B pertussis | 4 | 0.2 |
Coronavirus-229e | 29 | 1.3 |
Coronavirus-HKU1 | 39 | 1.8 |
Coronavirus-NL63 | 31 | 1.4 |
Coronavirus-OC43 | 57 | 3 |
Enterovirus | 107 | 5 |
Influenza-A | 14 | 0.6 |
Influenza-B | 5 | 0.2 |
HMPV | 155 | 7 |
HRV | 564 | 26 |
M pneumoniae | 19 | 0.9 |
Novel H1N1a | 7 | 0.3 |
PIV1 | 17 | 0.8 |
PIV2 | 11 | 0.5 |
PIV3 | 30 | 1.4 |
RSV-A | 940 | 43 |
RSV-B | 664 | 30 |
Atelectasis on chest x-ray | 272 | 12 |
Infiltrate on chest x-ray | 285 | 13 |
Hyperinflated on chest x-ray | 384 | 17 |
Peribronchial cuffing on chest x-ray | 399 | 23 |
Normal chest x-ray | 314 | 14 |
ABG, arterial blood gas; HMPV, human metapneumovirus; PIV, parainfluenza virus; WBC, white blood count.
Only checked in year 3 when novel H1N1 was circulating (n = 854).
Unadjusted associations between demographic and clinical characteristics and needing CPAP/intubation during the inpatient stay are presented in Table 2. In general, the children most likely to require CPAP/intubation were younger, born between the months of October and March, nonblack race, had a gestational age of 32 to 36 weeks, a birth weight <7 pounds, and began experiencing difficulty breathing <1 day before coming to the ED. Furthermore, clinical factors recorded during the ED visit such as apnea, lower weight, faster pulse, severe retractions, lower oxygen saturations, inadequate oral intake, and nonnormal chest x-ray results all were associated with CPAP/intubation. Furthermore, oxygen saturation, retractions, and oral intake were significantly associated with each other (P < .001 for all associations). No association was detected between the most common viruses, including coinfections, and CPAP/intubation.
TABLE 2.
Characteristics | No CPAP/Intubation (n = 1998), % | CPAP/Intubation (n = 161), % | P |
---|---|---|---|
Age in months | |||
<2 | 27 | 46 | <.001 |
2–5.9 | 35 | 34 | |
6–11.9 | 23 | 14 | |
≥12 | 15 | 6 | |
Month of birth | .002 | ||
October–March | 60 | 73 | |
April–September | 40 | 27 | |
Gender | .67 | ||
Male | 59 | 61 | |
Female | 41 | 39 | |
Race | .01 | ||
White | 61 | 64 | |
Black | 25 | 16 | |
Other or missing | 14 | 20 | |
Hispanic | 36 | 43 | .07 |
Insurance | .65 | ||
Nonprivate | 69 | 67 | |
Private | 31 | 33 | |
Gestational age, wk | .02 | ||
<32 | 7 | 5 | |
32–36 | 17 | 26 | |
≥37 or term | 76 | 69 | |
Birth weight, lbs | .01 | ||
<5 | 13 | 16 | |
≥5 | 35 | 42 | |
≥7 | 53 | 42 | |
Mother’s age, median (IQR) | 27 (23–33) | 28 (23–33) | .61 |
Is or was breastfed | 61 | 57 | .28 |
Smoked during pregnancy | 15 | 19 | .12 |
Exposure to smoke | 13 | 11 | .38 |
Family history of asthma | .73 | ||
Neither parent | 67 | 66 | |
Either mother or father | 27 | 30 | |
Both parents | 4 | 2 | |
Don't know/missing | 2 | 2 | |
History of infant wheezing | 23 | 19 | .22 |
History of infant eczema | 16 | 11 | .10 |
History of infant intubation | 10 | 11 | .67 |
Major, relevant, comorbid medical disorder | 22 | 17 | .16 |
When difficulty breathing began (preadmission) | .003 | ||
≥1 d | 71 | 59 | |
<1 d | 26 | 39 | |
No difficulty preadmission | 2 | 2 | |
Presence of apnea (chart) | 5 | 28 | <.001 |
Weight (lbs), median (IQR) | 13 (9–18) | 10 (7–14) | <.001 |
Temperature (F), median (IQR) | 99.5 (98.6–100.6) | 99.4 (98.2–100.7) | .17 |
Pulse (beats per min), median (IQR) | 160 (147–175) | 173 (155–184) | <.001 |
Respiratory rate (breaths per min), median (IQR) | 48 (40–60) | 50 (40–60) | .17 |
Retractions | <.001 | ||
None | 22 | 15 | |
Mild | 43 | 21 | |
Moderate | 25 | 34 | |
Severe | 3 | 20 | |
Missing | 7 | 10 | |
Oxygen saturation by pulse oximeter or ABG | <.001 | ||
<85 | 3 | 17 | |
85–87.9 | 3 | 6 | |
88–89.9 | 4 | 6 | |
90–93.9 | 17 | 16 | |
≥94 | 73 | 55 | |
Oral intake | <.001 | ||
Adequate | 45 | 20 | |
Inadequate | 41 | 63 | |
Missing | 14 | 16 | |
WBC, median (IQR) | 11 (9–15) | 11 (9–15) | .59 |
Platelets, median (IQR) | 395 (311–488) | 413 (325–517) | .12 |
RSV-A | 42 | 45 | .57 |
RSV-B | 30 | 29 | .81 |
HRV | 25 | 27 | .73 |
Atelectasis on chest x-ray | 11 | 27 | <.001 |
Infiltrate on chest x-ray | 12 | 29 | <.001 |
Hyperinflated on chest x-ray | 17 | 20 | .28 |
Peribronchial cuffing on chest x-ray | 22 | 25 | .53 |
Normal chest x-ray | 15 | 6 | .001 |
ABG, arterial blood gas; WBC, white blood count.
The bootstrapped multivariable logistic regression model for CPAP/intubation is shown in Table 3. Controlling for 10 demographic and clinical characteristics as well as clustering by site, significant independent predictors of CPAP/intubation were as follows: age <6 months, birth weight <7 pounds, maternal smoking during pregnancy, onset of breathing difficulties <1 day before ED visit, presence of apnea, presence of severe retractions, oxygen saturation <85%, and inadequate oral intake. Gender and race were not associated with CPAP/intubation. The optimism-corrected c-statistic for the final model was 0.80, and the Hosmer-Lemeshow test demonstrated a good model fit (P = .65).
TABLE 3.
Characteristics | OR | BCa 95% CI |
---|---|---|
Age in months | ||
<2 | 4.29 | 1.66–11.53 |
2–5.9 | 2.61 | 1.16–6.10 |
6–11.9 | 1.59 | 0.68–4.94 |
≥12 | 1.00 | (reference) |
Gender | ||
Male | 1.00 | (reference) |
Female | 0.86 | 0.56–1.40 |
Race | ||
White | 1.00 | (reference) |
Black | 0.66 | 0.31–1.21 |
Other or missing | 1.44 | 0.57–2.97 |
Birth weight, pounds | ||
<5 | 1.70 | 1.01–2.52 |
≥5 | 1.68 | 1.03–2.68 |
≥7 | 1.00 | (reference) |
Smoked during pregnancy | 1.38 | 1.05–1.91 |
When difficulty breathing began (preadmission) | ||
≥1 d | 1.00 | (reference) |
<1 d | 1.58 | 1.15–2.09 |
No difficulty preadmission | 0.59 | 0.12–3.41 |
Presence of apnea (chart) | 4.78 | 2.57–8.50 |
Retractions | ||
None | 1.00 | (reference) |
Mild | 0.83 | 0.45–1.68 |
Moderate | 2.36 | 0.77–5.38 |
Severe | 11.14 | 2.40–33.19 |
Missing | 1.78 | 0.27–4.55 |
Oxygen saturation by pulse oximeter or ABG | ||
<85 | 3.28 | 2.02–4.82 |
85–87.9 | 1.34 | 0.57–3.43 |
88–89.9 | 1.91 | 0.79–3.80 |
90–93.9 | 1.15 | 0.70–1.52 |
≥94 | 1.00 | (reference) |
Oral intake | ||
Adequate | 1.00 | (reference) |
Inadequate | 2.51 | 1.34–4.26 |
Missing | 2.47 | 1.34–5.07 |
BCa 95% CI, bias-corrected and accelerated 95% confidence intervals; ABG, arterial blood gas.
Of the 161 children requiring CPAP/intubation, 42 (26%) were identified as having rapidly declined (ie, breathing difficulties began <1 day from the ED visit and needed CPAP/intubation on the first day of their hospitalization). Among these 42 children with rapidly deteriorating conditions, 50% were <2 months of age, 60% were male, 60% were white, and 55% were Hispanic. In addition, 55% had a birth weight of <7 pounds, 38% had apnea, 29% had severe retractions, 11% had an oxygen saturation of <85%, 69% were noted to have inadequate oral intake, 50% were positive for RSV-A, and only 1 child was reported to have normal chest x-ray results. A separate, but overlapping group of children were those requiring mechanical respiratory support on the first day of their hospitalization no matter when the breathing difficulty began (ie, <1 day or ≥ 1 day). Compared with the group of children who needed CPAP/intubation after day 1 of hospitalization, the children requiring CPAP/intubation on day 1 were more likely to have RSV-A (51% vs 31%, P = .03) and apnea (36% vs 3%; P < .001).
Discussion
In this large, multicenter, multiyear prospective study of children hospitalized with bronchiolitis, we found several factors independently associated with a child’s need for CPAP and/or intubation: young age, low birth weight, child of mother who smoked during pregnancy, onset of respiratory symptoms <1 day before presentation, presence of apnea, severe retractions, room air oxygen saturation <85%, and inadequate oral intake. Although viral etiology was not predictive of the need for mechanical respiratory support overall, RSV-A was more common in those children requiring CPAP/intubation on day 1 of hospitalization. Furthermore, these data build on and corroborate previous findings about the severe respiratory ramifications of smoke exposure in utero, a finding of public health importance. A novel finding of clinical and research importance was the identification of a subgroup of children that rapidly declined from the onset of respiratory symptoms at home to requiring CPAP and/or intubation.
Previous studies have examined risk factors for hospitalization,6,28,39–42 ICU admissions,16 CPAP,43 and intubation.6,29,44,45 However, of the studies that used CPAP or intubation as the outcome, 3 were retrospective, single-center studies.29,43,44 Furthermore, the 2 prospective intubation studies had sample sizes of 636 and 1945 children and only included children with RSV. These comprehensive, prospective, multicenter data examining 161 children requiring CPAP and/or intubation have confirmed some previous findings, challenged others, and revealed new findings that deserve attention.
Two of the most consistently identified risk factors for severe bronchiolitis are young age and low birth weight. Regarding young age, several studies have identified age <6 weeks as predictive of severe bronchiolitis,6,46,47 but we found that, although children <2 months had the highest odds of requiring CPAP/intubation, children up to age 6 months also had an increased odds compared with children >1 year of age. In terms of birth weight, Rietveld and colleagues’ retrospective study comparing 2469 children hospitalized with RSV with 140 661 children with RSV infection who were not hospitalized found multivariable ORs similar to our data for children ≤2.5 kg (adjusted OR, 1.7; 95%CI, 1.5–2.0) and >2.5 to 3.0 kg (adjusted OR, 1.3; 95%CI, 1.1–1.4).42
On initial presentation, the clinical factors of apnea, severe retractions, room air oxygen saturation <85%, and inadequate oral intake all independently predicted the need for CPAP and/or intubation. These 4 factors clearly paint the picture of an infant in respiratory distress and, although beyond the scope of this analysis, may be markers for children who are born with reduced lung function.48–50 One of these 4 factors is apnea, and we found in a previous prospective study that apnea in the ED was associated with ICU admission.16 Similarly, a retrospective chart review study of 185 children aged <12 months with RSV bronchiolitis by Kneyber and colleagues21 found that children with apnea were more likely to be intubated. These prospective data confirm that apnea is a serious event in children with bronchiolitis and predicts the need for CPAP and/or intubation. Another factor of interest was room air oxygen saturation. Compared with the referent room air oxygen saturation value of >94%, oxygen saturation values between 85% and 93.9% were not predictive of CPAP/intubation. However, children with <85% oxygen saturation were more likely to require CPAP and/or intubation, and this value is lower than the previously identified value of 90%, which represents the inflection point on the oxyhemoglobin dissociation curve.6 These oxygen saturation data provide a different, less conservative perspective about the severity of a child’s bronchiolitis illness that may help to more appropriately triage children to intensive care.
Also of interest were the factors not associated with the need for mechanical respiratory support. For example, previous studies suggest that boys are more likely than girls to have severe bronchiolitis,5,9 but in the present data we did not find an association between gender and the severe bronchiolitis outcome, defined as requiring CPAP and/or intubation. Regarding the viral etiology of bronchiolitis, some data suggest that RSV-A24,25 and viral coinfections51,52 are associated with more severe bronchiolitis symptoms. We found that RSV-A is more common in children requiring CPAP/intubation on the day of admission, but not more common overall among children requiring mechanical respiratory support. Moreover, our previous data identify that children with RSV/HRV coinfections have a protracted severe illness, but not necessarily a higher intensity of illness as represented by intensive care outcomes, such as CPAP/ intubation.3
Children born to mothers who smoked during pregnancy have impaired lung function at birth53 that has been shown to persist through childhood.54,55 Furthermore, smoke exposure increases the incidence and severity of bronchiolitis.19,56–58 Our smoke exposure data extend these findings and are the first to demonstrate that maternal smoking during pregnancy is independently associated with bronchiolitis requiring CPAP and/or intubation even after controlling for 9 other factors. Different mechanisms for the harmful effects of smoke exposure have been examined, but they are beyond the scope of this analysis.59,60 These data clearly demonstrate the respiratory risks associated with in utero smoke exposure and reemphasize the priority that should be placed on smoking cessation, especially in pregnant women.61
Another interesting finding is that almost 40% of the children who required mechanical respiratory support on the day of presentation had difficulty breathing for <1 day before presentation. Fortunately, no child in our study died. Nevertheless, it is informative to compare the tempo of respiratory decline in this subgroup of children with bronchiolitis with descriptions of children with influenza who died during 2 recent influenza seasons. Bhat and colleagues62 described that, during the 2003–2004 influenza season, 29% of children died within 3 days of the onset of illness and 5% died within 1 day. In addition, in a description of the 2009 novel H1N1 pandemic in Argentina, Libster and colleagues63 described that 3 children (23%) died within 3 days of the onset of symptoms. Although there are few data on this topic, high levels of cytokines have been associated with reduced severity of illness in bronchiolitis,64,65 which is the opposite for influenza.66 Further study on the acute immune responses of this subgroup of children who have rapid respiratory decline may provide further insight into how RSV and HRV pathogenesis may differ from influenza in infants.
The current study has potential limitations. The study participants were enrolled in academic medical centers, and, therefore, these results may not be generalizable to community medical centers. Furthermore, there is institutional variability in care and resource utilization, including CPAP and intubation, for children with bronchiolitis not explained by severity of illness.7 Commenting on the appropriateness of these procedures is beyond the scope of these data. However, CPAP and intubation are major interventions with associated complications,33–36 and this outcome should have less practice variability than admission to the ICU. In addition, this was an observational study, and, therefore, the chest radiographs were not performed systematically. Despite our intriguing results, we did not include this variable in the multivariable models given the high potential for bias. Last, mothers who smoke during pregnancy continue to smoke after delivery and it is difficult to distinguish between environmental exposure to smoke in utero or ex utero. Nonetheless, these smoking data provide more evidence to continue to encourage smoking cessation.
Conclusions
In summary, on the basis of these prospective, multicenter, multiyear data of children hospitalized with bronchiolitis, we found for the first time that in utero smoke exposure is independently associated with a subsequent need for CPAP and/or intubation. The present data not only build on and extend previous findings about the respiratory ramifications of in utero smoke exposure for infants, but they also emphasize the need for continued work on smoking cessation. In addition to the demographic, historical, and clinical variables that predicted the need for mechanical respiratory support, we found a novel subgroup of children with bronchiolitis that have a rapid respiratory decline. Although this large study has clarified the characteristics of the children who have the most severe bronchiolitis, the next steps are to examine why and how these children differ from the majority of children who do not require mechanical respiratory support. As bronchiolitis research moves forward, the subgroup of children with rapid respiratory decline will be of particular interest and may yield important insights for the future management of children with bronchiolitis.
Collaborators in the MARC-30 Study
Besh Barcega, MD (Loma Linda Medical Center); John Cheng, MD, and Carlos Delgado, MD (Children’s Healthcare of Atlanta); Haitham Haddad, MD (Rainbow Babies & Children’s Hospital); Frank LoVecchio, MD (Maricopa Medical Center); Charles G. Macias, MD (MPH Texas Children’s Hospital); Eugene Mowad, MD (Children’s Hospital Akron); Brian Pate, MD (Children’s Mercy Hospital); Mark Riederer, MD, and Paul Hain, MD (Children’s Hospital at Vanderbilt); M Jason Sanders, MD (Children’s Memorial Hermann Hospital); Alan Schroeder, MD (Santa Clara Valley Medical Center); Nikhil Shah, MD, and Dorothy Damore, MD (New York Presbyterian Hospital–Cornell); Michelle Stevenson, MD (Kosair Children's Hospital); Erin Stucky, MD (Rady Children’s Hospital); Stephen Teach, MD, MPH (Children’s National Medical Center); and Lisa Zaoutis, MD (Children’s Hospital of Philadelphia).
Glossary
- CI
confidence intervals
- CPAP
continuous positive airway pressure
- ED
emergency department
- HRV
human rhinovirus
- IQR
interquartile ranges
- MARC
Multicenter Airway Research Collaboration
- NPA
nasopharyngeal aspirate
- OR
odds ratio
- PCR
polymerase chain reaction
- RSV
respiratory syncytial virus
Footnotes
Drs Mansbach, and Piedra, Ms Sullivan, and Dr Camargo were responsible for study concept and design; Drs Mansbach, Piedra, and Stevenson, Ms Sullivan, Mr Forgey, Ms Espinola, and Dr Camargo were responsible for acquisition of data; Drs Mansbach, Piedra, Stevenson, and Clark, Ms Espinola, and Dr Camargo were responsible for analysis and interpretation of data; Drs Mansbach, and Clark, Ms Espinola, and Dr Camargo drafted the manuscript; Drs Mansbach, Piedra, and Stevenson, Ms Sullivan, Mr Forgey, Dr Clark, Ms Espinola, and Dr Camargo were responsible for critical revision of the manuscript for important intellectual content; and all authors were responsible for final approval of version to be published.
FINANCIAL DISCLOSURE: The authors have indicated they have no financial relationships relevant to this article to disclose.
FUNDING: This study was supported by the grants U01 AI-67693 and K23 AI-77801 from the National Institutes of Health (Bethesda, MD). The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. Funded by the National Institutes of Health (NIH).
References
- 1.Carroll KN, Gebretsadik T, Griffin MR, et al. Increasing burden and risk factors for bronchiolitis-related medical visits in infants enrolled in a state health care insurance plan. Pediatrics. 2008;122(1):58–64 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Stockman LJ, Curns AT, Anderson LJ, Fischer-Langley G. Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006. Pediatr Infect Dis J. 2012;31(1):5–9 [DOI] [PubMed] [Google Scholar]
- 3.Mansbach JM, Piedra PA, Teach SJ, et al. for the MARC-30 Investigators . Prospective, multicenter study of viral etiology and hospital length-of-stay in children with severe bronchiolitis [published online ahead of print April 2, 2012]. Arch Pediatr Adolesc Med. 10.1001/archpediatrics.2011.1669 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Boyce TG, Mellen BG, Mitchel EF, Jr, Wright PF, Griffin MR. Rates of hospitalization for respiratory syncytial virus infection among children in medicaid. J Pediatr. 2000;137(6):865–870 [DOI] [PubMed] [Google Scholar]
- 5.Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA. 1999;282(15):1440–1446 [DOI] [PubMed] [Google Scholar]
- 6.Wang EE, Law BJ, Stephens D. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr. 1995;126(2):212–219 [DOI] [PubMed] [Google Scholar]
- 7.Willson DF, Horn SD, Hendley JO, Smout R, Gassaway J. Effect of practice variation on resource utilization in infants hospitalized for viral lower respiratory illness. Pediatrics. 2001;108(4):851–855 [DOI] [PubMed] [Google Scholar]
- 8.Holman RC, Shay DK, Curns AT, Lingappa JR, Anderson LJ. Risk factors for bronchiolitis-associated deaths among infants in the United States. Pediatr Infect Dis J. 2003;22(6):483–490 [DOI] [PubMed] [Google Scholar]
- 9.Shay DK, Holman RC, Roosevelt GE, Clarke MJ, Anderson LJ. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. J Infect Dis. 2001;183(1):16–22 [DOI] [PubMed] [Google Scholar]
- 10.Christakis DA, Cowan CA, Garrison MM, Molteni R, Marcuse E, Zerr DM. Variation in inpatient diagnostic testing and management of bronchiolitis. Pediatrics. 2005;115(4):878–884 [DOI] [PubMed] [Google Scholar]
- 11.Wang EE, Law BJ, Boucher FD, et al. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr. 1996;129(3):390–395 [DOI] [PubMed] [Google Scholar]
- 12.Mallory MD, Shay DK, Garrett J, Bordley WC. Bronchiolitis management preferences and the influence of pulse oximetry and respiratory rate on the decision to admit. Pediatrics. 2003;111(1). Available at: www.pediatrics.org/cgi/content/full/111/1/e45 [DOI] [PubMed] [Google Scholar]
- 13.American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis . Diagnosis and management of bronchiolitis. Pediatrics. 2006;118(4):1774–1793 [DOI] [PubMed] [Google Scholar]
- 14.Carroll KN, Wu P, Gebretsadik T, et al. The severity-dependent relationship of infant bronchiolitis on the risk and morbidity of early childhood asthma. J Allergy Clin Immunol. 2009;123(5):1055–1061, 1061.e1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Eriksson M, Bennet R, Nilsson A. Wheezing following lower respiratory tract infections with respiratory syncytial virus and influenza A in infancy. Pediatr Allergy Immunol. 2000;11(3):193–197 [DOI] [PubMed] [Google Scholar]
- 16.Damore D, Mansbach JM, Clark S, Ramundo M, Camargo CA, Jr. Prospective multicenter bronchiolitis study: predicting intensive care unit admissions. Acad Emerg Med. 2008;15(10):887–894 [DOI] [PubMed] [Google Scholar]
- 17.Mansbach JM, Clark S, Christopher NC, et al. Prospective multicenter study of bronchiolitis: predicting safe discharges from the emergency department. Pediatrics. 2008;121(4):680–688 [DOI] [PubMed] [Google Scholar]
- 18.Holberg CJ, Wright AL, Martinez FD, Ray CG, Taussig LM, Lebowitz MD. Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first year of life. Am J Epidemiol. 1991;133(11):1135–1151 [DOI] [PubMed] [Google Scholar]
- 19.Carroll KN, Gebretsadik T, Griffin MR, et al. Maternal asthma and maternal smoking are associated with increased risk of bronchiolitis during infancy. Pediatrics. 2007;119(6):1104–1112 [DOI] [PubMed] [Google Scholar]
- 20.McConnochie KM, Roghmann KJ. Parental smoking, presence of older siblings, and family history of asthma increase risk of bronchiolitis. Am J Dis Child. 1986;140(8):806–812 [DOI] [PubMed] [Google Scholar]
- 21.Kneyber MC, Brandenburg AH, de Groot R, et al. Risk factors for respiratory syncytial virus associated apnoea. Eur J Pediatr. 1998;157(4):331–335 [DOI] [PubMed] [Google Scholar]
- 22.Willwerth BM, Harper MB, Greenes DS. Identifying hospitalized infants who have bronchiolitis and are at high risk for apnea. Ann Emerg Med. 2006;48(4):441–447 [DOI] [PubMed] [Google Scholar]
- 23.DeVincenzo JP, El Saleeby CM, Bush AJ. Respiratory syncytial virus load predicts disease severity in previously healthy infants. J Infect Dis. 2005;191(11):1861–1868 [DOI] [PubMed] [Google Scholar]
- 24.Papadopoulos NG, Gourgiotis D, Javadyan A, et al. Does respiratory syncytial virus subtype influences the severity of acute bronchiolitis in hospitalized infants? Respir Med. 2004;98(9):879–882 [DOI] [PubMed] [Google Scholar]
- 25.McConnochie KM, Hall CB, Walsh EE, Roghmann KJ. Variation in severity of respiratory syncytial virus infections with subtype. J Pediatr. 1990;117(1 pt 1):52–62 [DOI] [PubMed] [Google Scholar]
- 26.Papoff P, Moretti C, Cangiano G, et al. Incidence and predisposing factors for severe disease in previously healthy term infants experiencing their first episode of bronchiolitis. Acta Paediatr. 2011;100(7):e17–e23 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Parker MJ, Allen U, Stephens D, Lalani A, Schuh S. Predictors of major intervention in infants with bronchiolitis. Pediatr Pulmonol. 2009;44(4):358–363 [DOI] [PubMed] [Google Scholar]
- 28.Purcell K, Fergie J. Driscoll Children’s Hospital respiratory syncytial virus database: risk factors, treatment and hospital course in 3308 infants and young children, 1991 to 2002. Pediatr Infect Dis J. 2004;23(5):418–423 [DOI] [PubMed] [Google Scholar]
- 29.Lebel MH, Gauthier M, Lacroix J, Rousseau E, Buithieu M. Respiratory failure and mechanical ventilation in severe bronchiolitis. Arch Dis Child. 1989;64(10):1431–1437 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Beckham JD, Cadena A, Lin J, et al. Respiratory viral infections in patients with chronic, obstructive pulmonary disease. J Infect. 2005;50(4):322–330 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Knorr L, Fox JD, Tilley PA, Ahmed-Bentley J. Evaluation of real-time PCR for diagnosis of Bordetella pertussis infection. BMC Infect Dis. 2006;6:62. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Winchell JM, Thurman KA, Mitchell SL, Thacker WL, Fields BS. Evaluation of three real-time PCR assays for detection of Mycoplasma pneumoniae in an outbreak investigation. J Clin Microbiol. 2008;46(9):3116–3118 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Easley RB, Segeleon JE, Haun SE, Tobias JD. Prospective study of airway management of children requiring endotracheal intubation before admission to a pediatric intensive care unit. Crit Care Med. 2000;28(6):2058–2063 [DOI] [PubMed] [Google Scholar]
- 34.Boswell WC, McElveen N, Sharp M, Boyd CR, Frantz EI. Analysis of prehospital pediatric and adult intubation. Air Med J. 1995;14(3):125–127, discussion 127–128 [DOI] [PubMed] [Google Scholar]
- 35.Nakayama DK, Gardner MJ, Rowe MI. Emergency endotracheal intubation in pediatric trauma. Ann Surg. 1990;211(2):218–223 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Aijian P, Tsai A, Knopp R, Kallsen GW. Endotracheal intubation of pediatric patients by paramedics. Ann Emerg Med. 1989;18(5):489–494 [DOI] [PubMed] [Google Scholar]
- 37.Steyerberg EW. Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating. New York, NY: Springer Science and Business Media; 2009 [Google Scholar]
- 38.Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons; 1989 [Google Scholar]
- 39.Shaw KN, Bell LM, Sherman NH. Outpatient assessment of infants with bronchiolitis. Am J Dis Child. 1991;145(2):151–155 [DOI] [PubMed] [Google Scholar]
- 40.Voets S, van Berlaer G, Hachimi-Idrissi S. Clinical predictors of the severity of bronchiolitis. Eur J Emerg Med. 2006;13(3):134–138 [DOI] [PubMed] [Google Scholar]
- 41.Walsh P, Rothenberg SJ, O’Doherty S, Hoey H, Healy R. A validated clinical model to predict the need for admission and length of stay in children with acute bronchiolitis. Eur J Emerg Med. 2004;11(5):265–272 [DOI] [PubMed] [Google Scholar]
- 42.Rietveld E, Vergouwe Y, Steyerberg EW, Huysman MW, de Groot R, Moll HA, RSV Study Group Southwest Netherlands . Hospitalization for respiratory syncytial virus infection in young children: development of a clinical prediction rule. Pediatr Infect Dis J. 2006;25(3):201–207 [DOI] [PubMed] [Google Scholar]
- 43.Evans J, Marlais M, Abrahamson E. Clinical predictors of nasal continuous positive airway pressure requirement in acute bronchiolitis. Pediatr Pulmonol. 2012;47(4):381–385 [DOI] [PubMed] [Google Scholar]
- 44.Prodhan P, Sharoor-Karni S, Lin J, Noviski N. Predictors of respiratory failure among previously healthy children with respiratory syncytial virus infection. Am J Emerg Med. 2011;29(2):168–173 [DOI] [PubMed] [Google Scholar]
- 45.Tissing WJ, van Steensel-Moll HA, Offringa M. Risk factors for mechanical ventilation in respiratory syncytial virus infection. Eur J Pediatr. 1993;152(2):125–127 [DOI] [PubMed] [Google Scholar]
- 46.Green M, Brayer AF, Schenkman KA, Wald ER. Duration of hospitalization in previously well infants with respiratory syncytial virus infection. Pediatr Infect Dis J. 1989;8(9):601–605 [DOI] [PubMed] [Google Scholar]
- 47.Opavsky MA, Stephens D, Wang EE, Pediatric Investigators Collaborative Network on Infections in Canada . Testing models predicting severity of respiratory syncytial virus infection on the PICNIC RSV database. Arch Pediatr Adolesc Med. 1995;149(11):1217–1220 [DOI] [PubMed] [Google Scholar]
- 48.Martinez FD, Morgan WJ, Wright AL, Holberg CJ, Taussig LM. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N Engl J Med. 1988;319(17):1112–1117 [DOI] [PubMed] [Google Scholar]
- 49.Hoo AF, Stocks J, Lum S, et al. Development of lung function in early life: influence of birth weight in infants of nonsmokers. Am J Respir Crit Care Med. 2004;170(5):527–533 [DOI] [PubMed] [Google Scholar]
- 50.van der Zalm MM, Uiterwaal CS, Wilbrink B, Koopman M, Verheij TJ, van der Ent CK. The influence of neonatal lung function on rhinovirus-associated wheeze. Am J Respir Crit Care Med. 2011;183(2):262–267 [DOI] [PubMed] [Google Scholar]
- 51.Semple MG, Cowell A, Dove W, et al. Dual infection of infants by human metapneumovirus and human respiratory syncytial virus is strongly associated with severe bronchiolitis. J Infect Dis. 2005;191(3):382–386 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Richard N, Komurian-Pradel F, Javouhey E, et al. The impact of dual viral infection in infants admitted to a pediatric intensive care unit associated with severe bronchiolitis. Pediatr Infect Dis J. 2008;27(3):213–217 [DOI] [PubMed] [Google Scholar]
- 53.Hanrahan JP, Tager IB, Segal MR, et al. The effect of maternal smoking during pregnancy on early infant lung function. Am Rev Respir Dis. 1992;145(5):1129–1135 [DOI] [PubMed] [Google Scholar]
- 54.Li YF, Gilliland FD, Berhane K, et al. Effects of in utero and environmental tobacco smoke exposure on lung function in boys and girls with and without asthma. Am J Respir Crit Care Med. 2000;162(6):2097–2104 [DOI] [PubMed] [Google Scholar]
- 55.Tager IB, Ngo L, Hanrahan JP. Maternal smoking during pregnancy. Effects on lung function during the first 18 months of life. Am J Respir Crit Care Med. 1995;152(3):977–983 [DOI] [PubMed] [Google Scholar]
- 56.Bradley JP, Bacharier LB, Bonfiglio J, et al. Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy. Pediatrics. 2005;115(1). Available at: www.pediatrics.org/cgi/content/full/115/1/e7 [DOI] [PubMed] [Google Scholar]
- 57.Jones LL, Hashim A, McKeever T, Cook DG, Britton J, Leonardi-Bee J. Parental and household smoking and the increased risk of bronchitis, bronchiolitis and other lower respiratory infections in infancy: systematic review and meta-analysis. Respir Res. 2011;12:5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Aligne CA, Stoddard JJ. Tobacco and children. An economic evaluation of the medical effects of parental smoking. Arch Pediatr Adolesc Med. 1997;151(7):648–653 [DOI] [PubMed] [Google Scholar]
- 59.Groskreutz DJ, Monick MM, Babor EC, et al. Cigarette smoke alters respiratory syncytial virus-induced apoptosis and replication. Am J Respir Cell Mol Biol. 2009;41(2):189–198 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Kott KS, Salt BH, McDonald RJ, Jhawar S, Bric JM, Joad JP. Effect of secondhand cigarette smoke, RSV bronchiolitis and parental asthma on urinary cysteinyl LTE4. Pediatr Pulmonol. 2008;43(8):760–766 [DOI] [PubMed] [Google Scholar]
- 61.Best D, Committee on Environmental Health. Committee on Native American Child Health. Committee on Adolescence . From the American Academy of Pediatrics: Technical report—Secondhand and prenatal tobacco smoke exposure. Pediatrics. 2009;124(5). Available at: www.pediatrics.org/cgi/content/full/124/5/e1017 [DOI] [PubMed] [Google Scholar]
- 62.Bhat N, Wright JG, Broder KR, et al. Influenza Special Investigations Team . Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med. 2005;353(24):2559–2567 [DOI] [PubMed] [Google Scholar]
- 63.Libster R, Bugna J, Coviello S, et al. Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. N Engl J Med. 2010;362(1):45–55 [DOI] [PubMed] [Google Scholar]
- 64.Bennett BL, Garofalo RP, Cron SG, et al. Immunopathogenesis of respiratory syncytial virus bronchiolitis. J Infect Dis. 2007;195(10):1532–1540 [DOI] [PubMed] [Google Scholar]
- 65.García C, Soriano-Fallas A, Lozano J, et al. Decreased innate immune cytokine responses correlate with disease severity in children with respiratory syncytial virus and human rhinovirus bronchiolitis. Pediatr Infect Dis J. 2012;31(1):86–89 [DOI] [PubMed] [Google Scholar]
- 66.Teijaro JR, Walsh KB, Cahalan S, et al. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell. 2011;146(6):980–991 [DOI] [PMC free article] [PubMed] [Google Scholar]